Status:
COMPLETED
To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia
Lead Sponsor:
Zeria Pharmaceutical
Conditions:
Functional Dyspepsia
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
To evaluate the efficacy and safety of Z-338 in subjects with Functional Dyspepsia
Eligibility Criteria
Inclusion
- Subjects presenting diagnosis of FD as defined by the Rome II
- Subjects presenting postprandial fullness and/or Early satiety should be the most bothersome symptom
Exclusion
- \-
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2009
Estimated Enrollment :
282 Patients enrolled
Trial Details
Trial ID
NCT00323817
Start Date
April 1 2006
End Date
October 1 2009
Last Update
May 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leuven University
Leuven, Belgium